CompaniesOxford BioDynamics
Oxford BioDynamics logo

Oxford BioDynamics

active
Oxford, UK
Founded 2007
Website
About

Diagnostics

Areas of Focus

Categories

Diagnostics
Team (14)
Dr. Alexandre Akoulitchev MA, PhD, FRSM
Chief Scientific Officer
Oxford BioDynamics
executive
Dr. David Holbrook MA, MB BS, MBA
Non-Executive Director
Oxford BioDynamics
team_member
Dr. Ewan Hunter BSc, PhD
Chief Data Officer
Oxford BioDynamics
team_member
Iain Ross
Executive Chairman
Oxford BioDynamics
board_chair
Leadership that is committed to expanding the future of 3D genomics
Leadership that is committed to expanding the future of 3D genomics
Oxford BioDynamics
team_member
Paul Stockdale MA, FCA
Chief Financial Officer
Oxford BioDynamics
executive
View all 14 team members →
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

2,000

By Status

RECRUITING: 1

Recent Trials

NCT06635954Lead Sponsor
A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.
N/ARecruiting
2,000 participants
Started: May 14, 2024 · Completed: May 14, 2027
Funding History (1)
D
Nov 12, 2021
Filing
Locations (1)
Headquarters
Oxford, UK
Map

Loading map...